Table 3.

Relative frequencies of the six possible orderings among the expression values of the top-scoring triple for various studies. .

		Colon Study		DLBCL Study		Leukemia Study
	Ordering	Tumor	Normal	DLBCL	FL	ALL	AML
π1	Xi <Xj <Xk	0.125	0.045	0.362	0	0.340	0
π2	Xi <Xk <Xj	0.4	0	0.569	0	0	0.04
π3	Xj <Xi <Xk	0.075	0.864	0.052	0	0.660	0
π4	Xj <Xk <Xi	0	0.091	0	0.684	0	0.08
π5	Xk <Xi <Xj	0.4	0	0.017	0.053	0	0.76
π6	Xk <Xj <Xi	0	0	0	0.263	0	0.12
		Prostate1 Study		Lung Study		GCM Study
	Ordering	Cancer	Normal	MPM	ADCA	Tumor	Normal
π1	Xi <Xj <Xk	0.04	0	0	0.12	0.8	0.222
π2	Xi <Xk <Xj	0.1	0	0	0.827	0.113	0.5
π3	Xk <Xi <Xk	0.02	0.115	0.258	0.007	0.079	0.022
π4	Xj <Xk <Xi	0.06	0.807	0.742	0	0	0.044
π5	Xk <Xi <Xj	0.5	0.019	0	0.02	0.008	0.179
π6	Xk <Xj <Xi	0.28	0.059	0	0.027	0	0.033

Each portion of the corresponds to one study with two phenotypes. For each study and each phenotype, the table shows the relative frequencies of the six possible orderings among the expression values of the top-scoring triple for the samples in the study. The gene triple (g_i, g_j, g_k) for each study is given in Table 4